Shaheen's bipartisan
INSULIN Act would cap monthly out-of-pocket insulin costs at $35 a month for all Americans with insurance, expanding the effective price cap for Americans on Medicare. Currently, a majority of states do not have a $35 a month cap on insulin costs. Shaheen's
INSULIN Act would immediately change that, lowering prices for millions and ensuring that the state one lives in doesn't determine whether they can afford their life-saving insulin.
The Eagle-Tribune's editorial comes
as momentum continues to build for the
INSULIN Act, with both Senate Democrats and Republicans
expressing their support for the legislation in Washington last week.